GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regenxbio Inc (STU:RB0) » Definitions » Price-to-Funds-From-Operations

Regenxbio (STU:RB0) Price-to-Funds-From-Operations : (As of Dec. 13, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Regenxbio Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Regenxbio Business Description

Industry
Traded in Other Exchanges
Address
9804 Medical Center Drive, Rockville, MD, USA, 20850
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.